Stocks keep on gaining - Wednesday Review, November 11

By: Miguel A. Rodriguez

11:44, 12 November 2020

1605171262.jpg
The potential COVID-19 vaccine moved the markets for the third consecutive day

The US

The benchmarks traded mixedly, part of them reacting to the fact that new restrictions might be imposed to curb the spread of COVID-19. On the other hand, others were driven by Microsoft and Apple's success following the launch of their new products. USA30 fell 0.08%, while USA500 gained 0.78%. TECH100 added 2.01%.

Crude settled up 1.5% at $41.99 per barrel. Brent rose 1% at $44.05.

Gold settled down 0.8% at $1,861.40 per ounce.

The Dollar Index traded at 92.741.

 

Asia and Australia

The markets closed higher over optimism that a viable COVID-19 vaccine could be successfully developed and launched. HongKong45 gained 2.24%.

Japan225 rose 5.41%.

Down under, Australia200 traded 1.79% higher.

 

Europe

Pfizer's potential COVID-19 still impacted the markets. Also, Europe was looking forward to Christine Lagarde's speech regarding the economic outlook and stimulus prospects. Europe50 climbed 0.4%. Germany30hit a one-month high after adding 0.56%. France40 went up 0.4%, while UK100 closed 0.2% higher.

EUR/USD closed at 1.1827 after it gained 0.1%.

Sources: investing.com, reuters.com

Share this article

The information presented herein is prepared by CAPEX.com/eu and does not intend to constitute Investment Advice. The information herein is provided as a general marketing communication for information purposes only and as such it has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research.                                                                                                                            Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience, or current financial situation.Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance and forecasts are not reliable indicators of future results.